Old Articles: <Older 2051-2060 Newer> |
|
Chemistry World April 9, 2013 Phillip Broadwith |
Morning sickness drug reintroduced to US Diclegis (doxylamine succinate and pyridoxine hydrochloride), contains the same active ingredients as Benedictin, which was produced by Merrel Dow and withdrawn from the market in 1983 after a string of lawsuits claiming it caused birth defects. |
Chemistry World April 8, 2013 Emma Stoye |
New culprit for red meat health risks Gut bacteria may convert a nutrient found in red meat into a compound that can damage the heart |
Chemistry World April 7, 2013 Laura Howes |
Beer filtration could add arsenic Researchers at the Technical University of Munich, Germany, have found that the material used to filter beers might add arsenic at the same time as it removes yeast. |
Chemistry World April 5, 2013 Phillip Broadwith |
Roche to release Tamiflu trial data Swiss pharma company Roche has finally agreed to give independent researchers access to data on all 74 clinical trials it ran on the antiviral influenza drug Tamiflu (oseltamivir). |
Chemistry World April 2, 2013 Emma Stoye |
New diagnostic test lights up bacteria UK researchers have developed a faster way to detect Staphylococcus aureus bacteria using a fluorescent probe. The method holds promise as the basis for a new rapid diagnosis kit to identify infections in hospital patients. |
Chemistry World March 26, 2013 |
Germany, China create nanotech center Researchers in Germany and China have founded a new nanotechnology and biomedicine center to develop new materials, focusing on developing regenerative treatments for bone diseases. |
AskMen.com March 21, 2013 Jake Rossen |
Sleep Better Barring medical conditions that require a physician's attention -- like sleep apnea -- a few minor adjustments may be all you need for more restorative slumber. We look at some of the available consumer technologies that may help you get there. |
Pharmaceutical Executive March 1, 2013 Ben Comer |
Brand of the Year: Januvia When Merck's Januvia received its first regulatory approval, in Mexico in 2006, no one predicted its long-term success. In 2012, the company's diabetes franchise became the highest-selling product family in Merck's 122-year history. |
Pharmaceutical Executive March 1, 2013 |
Who's Really in Charge of European Drug Registration? The European Commission blocks the authorization of a life-saving liver drug outside of France. |
Chemistry World March 22, 2013 Melissae Fellet |
Painting circuits on skin Painting a patient's skin with a liquid metal ink could make heart monitoring much less painful and even let doctors keep an eye on a whole range of vital signs. |
<Older 2051-2060 Newer> Return to current articles. |